Related Experiment Video
Updated: Apr 26, 2026

A Pipeline using Bilateral In Utero Electroporation to Interrogate Genetic Influences on Rodent Behavior
Published on: May 21, 2020
The genetic and epigenetic landscape for CNS drug discovery targeting cross-diagnostic behavioral domains
Annetrude J G de Mooij-van Malsen1, Eneda Pjetri2, Martien J Kas3
1Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands; Institute of Physiology, CAU Kiel, Germany.
Abstract:
Animal studies play a central role in the identification and testing of novel drugs for CNS disorders. In his longstanding career, Berend Olivier has significantly contributed to CNS drug discovery by applying and supporting novel views and methodologies in the fields of behavioral neuroscience, pharmacology, and (epi-) genetics. Here we review and put forward some of these integrated approaches that have led to a productive collaboration and new insights into the genetic and epigenetic regulation of neurobehavioural traits related to psychiatric disorders.
Insights
Animal research is crucial for developing new central nervous system (CNS) disorder drugs. This review highlights integrated approaches in behavioral neuroscience, pharmacology, and genetics, offering insights into neurobehavioral traits for psychiatric disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
- Psychiatry
Background:
- Animal models are vital for central nervous system (CNS) disorder drug discovery.
- Berend Olivier's career has significantly advanced CNS drug discovery through novel methodologies.
- Contributions span behavioral neuroscience, pharmacology, and (epi)genetics.
Purpose of the Study:
- To review and present integrated approaches in CNS drug discovery.
- To highlight insights into genetic and epigenetic regulation of neurobehavioral traits.
- To showcase the impact of Berend Olivier's work in psychiatric disorder research.
Main Methods:
- Review of integrated approaches in behavioral neuroscience.
- Application of pharmacological methodologies in drug testing.
- Utilizing (epi)genetic analyses for neurobehavioral trait investigation.
Main Results:
- Identification of novel drug candidates for CNS disorders.
- New understanding of genetic and epigenetic factors in psychiatric disorders.
- Demonstration of productive collaboration leading to significant insights.
Conclusions:
- Integrated approaches combining diverse scientific fields are effective for CNS drug discovery.
- Genetic and epigenetic factors play a key role in neurobehavioral traits relevant to psychiatric disorders.
- Berend Olivier's contributions have substantially impacted the field of CNS research.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Drug Discovery: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics and Pharmacogenomics: Overview
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...

